Myopia Reports

Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic industry.

2026 Myopia Management Market Report: Global Analysis for 2025 to 2031, May, 2026

Market Scope’s first-edition “2026 Myopia Management Market Report” provides a data-driven view of one of ophthalmology’s fastest-growing segments, with a focus on the rising pediatric myopia population and the shift toward earlier intervention. It quantifies the total, addressable, and serviceable markets, with five-year forecasts and detailed analysis of treatment volumes, adoption trends, and competitive dynamics across key regions.  

The report provides deep segmentation across all major treatment categories—including myopia control spectacles, soft contact lenses, orthokeratology, and low-dose atropine—alongside insights into combination therapies, treatment efficacy, reimbursement, and barriers to adoption. It also examines the underlying drivers shaping demand, from demographic and lifestyle trends to provider behavior and access to care.  

Expanded coverage of diagnostic technologies, digital platforms, and emerging therapies paired with global market analysis and company profiles gives you a complete picture of where the market is today and where it’s headed.  

2025 Myopia Management Survey Report, December, 2025

Market Scope’s “2025 Myopia Management Survey Report” delivers a comprehensive, provider-level view of how pediatric myopia is being managed in the United States today—examining patient volumes, treatment mix, economics, unmet needs, and how clinical behavior is likely to shift as new therapies reach the market. 

Conducted in August and September 2025, the survey captures insights from 150 US-based optometrists and ophthalmologists, including comprehensive and pediatric specialists actively treating myopia. Respondents were drawn from Market Scope’s self-registered provider community and reflect real-world clinical decision-makers with direct experience in myopia control. 

The report provides a structured summary analysis of de-identified survey data, calculated at the respondent level and presented without market extrapolation to clearly show how providers are thinking, prescribing, pricing, and planning. 

Want to Purchase the Full Report?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more